Topic specific news, updated constantly
from the most reliable sources, all in one place.
Other NewsOnly
Information Pages
Information Pages
Anthera Announces Second Quarter 2010 Financial Report and Conference Call - PR Newswire (press release)
Anthera Announces Second Quarter 2010 Financial Report and Conference Call PR Newswire (press release) ... or BLyS, which has been associated with a variety of B-Cell mediated autoimmune diseases, including systemic erythematosus, or . ... |
Taper Lock raises money for Riley, - KPCnews.com
Taper Lock raises money for Riley, Lupus KPCnews.com This year Kristine Yoder, an employee with Taper Lock, will participate in the Walk for Now - The Foundation, Indiana Chapter on Oct. 9 in ... |
Human Genome Sciences signs supply deal with Lonza - BusinessWeek
 Genetic Engineering News | Human Genome Sciences signs supply deal with Lonza BusinessWeek Human Genome Sciences said Tuesday that Lonza will be the commercial supplier for its experimental drug. Benlysta is currently under regulatory review ... Lonza to produce lupus drug Benlysta for GlaxoSmithKline/Human Genome Sciences Human Genome Sciences and Lonza Enter Commercial Manufacturing Agreement for ... Notable Analyst Upgrades, Downgrades and Comments |
After baby's birth, she waits for new life - Times of India
After baby's birth, she waits for new life Times of India Selvi, a resident of Tiruvannamalai, was diagnosed with kidney failure triggered due to an autoimmune disease called systemic erythematosus, ... Haemodialysis patient gives birth to baby |
UT Southwestern researchers uncover biological rationale for why intensive ... - Health News - HealthCanal.com
UT Southwestern researchers uncover biological rationale for why intensive ... Health News - HealthCanal.com Unlike the anabolic steroids athletes sometimes use illegally to bulk up muscle, corticosteroids are routinely used to treat inflammation in patients. ... |
Anthera Initiates Expanded and Extended PEARL-SC Phase 2b Clinical Study in ... - DigitalJournal.com (press release)
Anthera Initiates Expanded and Extended PEARL-SC Phase 2b Clinical Study in ... DigitalJournal.com (press release) patients suffer from a chronic autoimmune disease, which often leads to severe skin rash, fatigue, joint pain, major organ complications, ... OTC ADVISORS, LLC: Huge Alert On: (NASDAQ:JMBA) - (NASDAQ:AVNR) - (NASDAQ:ANTH) |
Missing Detroit woman found - Detroit Free Press
Missing Detroit woman found Detroit Free Press A 45-year-old Detroit woman with and schizophrenia who disappeared three weeks ago today was found, her mother said today. Theresa Mack, who lives on ... |
Intensive Treatment More Effective at Killing Disease Cells - Kansas City infoZine
Intensive Lupus Treatment More Effective at Killing Disease Cells Kansas City infoZine Dallas, TX - infoZine – A biological rationale has been found for the effectiveness of administering massive doses of corticosteroids to patients ... |
3 Biotechs on Your Radar Screen - msnbc.com
3 Biotechs on Your Radar Screen msnbc.com In late June, it released further phase 2 data that showed its drug candidate for , epratuzumab, saw meaningful and statistically significant results ... Phase 3 Clinical Trial Data for Somaxon Pharmaceuticals' Insomnia Drug to Be ... |
Stem Cell Transplant Benefits Severe - MedPage Today
Stem Cell Transplant Benefits Severe Lupus MedPage Today Explain to interested patients that a small study found improvements in severe refractory with stem cell transplantation. But caution them that larger ... |